About this book
The Politics of Pharmaceutical Policy Reform: A Study of Generic Drug Regulation in Brazil, explores the following:
· The politics of pharmaceutical regulation in Brazil over the last 25 years.
· The political negotiations to approve the Generic Drug Act, which involved a hard-to-reach agreement between the pharmaceutical industry (national and multinational), the Ministry of Health, and Congress
· The controversial decisions to regulate packaging and pharmaceutical equivalence.
· The surprising success of Brazilian pharmaceutical firms, which became market champions in a sector largely dominated by multinational firms.
· Comparative lessons from the Brazilian case for the political construction of regulatory standards to regulate generic drugs and its effects on global health.
This book will interest political scientists and health policy scholars concerned with the political conflicts in the pharmaceutical sector. It argues against well-established approaches to regulatory capture such as control of the regulatory process by interest groups and policy diffusion. It can be used as evidence for graduate courses in public policy, health policy and political science. Because Brazil is one of the largest markets for pharmaceuticals in the world, business leaders and consultancy firms would also be interested.
- DOI https://doi.org/10.1007/978-3-319-12565-7
- Copyright Information Springer International Publishing Switzerland 2015
- Publisher Name Springer, Cham
- eBook Packages Business and Economics
- Print ISBN 978-3-319-12564-0
- Online ISBN 978-3-319-12565-7
- Series Print ISSN 2191-5466
- Series Online ISSN 2191-5474
- Buy this book on publisher's site